| 1 | Inhibition of Mitochondrial Dynamics Preferentially Targets Pancreatic Cancer Cells with Enhanced Tumorigenic and Invasive Potential. 2021;13:698 doi: 10.3390/cancers13040698 |
| 2 | Targeting Mitochondrial Oncometabolites: A New Approach to Overcome Drug Resistance in Cancer. 2021;13:762 doi: 10.3390/pharmaceutics13050762 |
| 3 | Long-Term Fenofibrate Treatment Stimulates the Phenotypic Microevolution of Prostate Cancer Cells In Vitro. 2022;15:1320 doi: 10.3390/ph15111320 |
| 4 | Targeting cancer-cell mitochondria and metabolism to improve radiotherapy response. 2021;14:100905 doi: 10.1016/j.tranon.2020.100905 |
| 5 | Involvement of Multidrug Resistance Modulators in the Regulation of the Mitochondrial Permeability Transition Pore. 2022;12:890 doi: 10.3390/membranes12090890 |
Cancer Drug Resistance
